Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166902 · ClinicalTrials.gov registry record · NA
Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
A NA study of Ametropia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 4
- Study locations
NCT05166902: Completed NA study of Ametropia, sponsored by CooperVision.
NCT05166902 is a NA study of Ametropia that has completed, run by CooperVision. The registered enrollment target is 67 participants, below the 142-participant average among 5 other Ametropia trials with a reported enrollment target (53% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05166902, a NA study of Ametropia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 4
- Study locations
Study Summary
To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.
Primary Outcome
Subjective ratings on lens handling on removal will be measured on a scale of 0-10, 0.5 steps (10= Very Easy, 0= Very Difficult)
Conditions Studied
Interventions
- DEVICE Lens A (comfilcon A lens)
- DEVICE Lens B (lehfilcon A lens)
Study Locations (4)
Ontario
- Eyes on Sheppard Clinic - Toronto
- Spadina Optometry - Toronto
Florida
- Coan Eye Care - Ocoee
Pennsylvania
- Nittany Eye Associate - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2022-07-09 |
| Phase | NA |
What the finished NCT05166902 record still lists
NCT05166902 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 142-participant average among 5 other Ametropia trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Ametropia appearing as the primary indexed condition, and to 2 interventions - of which Lens A (comfilcon A lens) is the first listed.
NCT05166902 reports a single indexed study location in Ontario, Florida, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05166902 about?
NCT05166902 is a clinical study titled "Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use". To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.
What is the current status of trial NCT05166902?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2022-01-31. Estimated completion is 2022-07-09.
What conditions does trial NCT05166902 study?
This clinical trial studies the following conditions: Ametropia.
What interventions are being tested in trial NCT05166902?
The interventions under investigation include: Lens A (comfilcon A lens) (DEVICE), Lens B (lehfilcon A lens) (DEVICE).
Who is sponsoring clinical trial NCT05166902?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05166902 being conducted?
This trial has 4 study locations across Florida, Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ametropia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
RECRUITING · NA
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Apioc Contact Lens Feasibility
COMPLETED · NA
-
North American Comfilcon A Clinical Study
RECRUITING
-
Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI